Total Voting Rights

Summary by AI ^BETAClose X

Bellevue Healthcare Trust plc has announced its total voting rights and capital as of 28 November 2025. The company's issued share capital comprises 315,152,309 ordinary shares, with 223,124,455 held in treasury, leaving 92,027,854 ordinary shares in circulation. This figure of 92,027,854 represents the total number of voting rights and should be used by shareholders for notification calculations under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

Bellevue Healthcare Trust PLC

01 December 2025

Bellevue Healthcare Trust plc

LEI: 213800HQ3J3H9YF2UI82

TOTAL VOTING RIGHTS AND CAPITAL

In conformity with Disclosure Guidance and Transparency Rule 5.6.1R, Bellevue Healthcare Trust plc (the "Company") notifies the market of the following:

On 28 November 2025, the issued share capital of the Company consisted of 315,152,309 Ordinary Shares of 1 pence each, of that amount 223,124,455 Ordinary Shares were held in Treasury and 92,027,854 Ordinary Shares were in circulation.

Therefore, the total number of voting rights in the Company is 92,027,854 (the 'Figure').

The Figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For the purposes of the Transparency Directive the Company's Home Member State is the United Kingdom.

Enquiries:

NSM Funds (UK) Limited

Company Secretary

bellevue@nsm.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END